Exploiting Interkingdom Interactions for Development of Small-Molecule Inhibitors of Candida albicans Biofilm Formation

A rapid decline in the development of new antimicrobial therapeutics has coincided with the emergence of new and more aggressive multidrug-resistant pathogens. Pathogens are protected from antibiotic activity by their ability to enter an aggregative biofilm state. Therefore, disrupting this process...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Reen, F. Jerry, Phelan, John P., Gallagher, Lorna, Woods, David F., Shanahan, Rachel M., Cano, Rafael, Ó Muimhneacháin, Eoin, McGlacken, Gerard P., O'Gara, Fergal
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038327/
https://ncbi.nlm.nih.gov/pubmed/27458231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00190-16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires